Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MSFT, UNP, AMZN, UNH, EL, and represent 22.08% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: CNC (+$101M), V (+$97M), LVS (+$88M), SPGI (+$85M), SCHW (+$83M), HUM (+$82M), JNJ (+$74M), XLE (+$53M), BBWI (+$50M), MCK (+$30M).
- Started 16 new stock positions in XLE, SCHW, WYNN, XOP, IOVA, HUM, BHVN, JNJ, BBWI, CNC. ACLX, V, AUPH, MCK, LVS, SPGI.
- Reduced shares in these 10 stocks: , AMZN (-$205M), ADI (-$144M), , ABC (-$133M), UNH (-$110M), MNST (-$110M), CVNA (-$99M), TMO (-$92M), OTIS (-$91M).
- Sold out of its positions in ABCL, ADBE, ALIT, ALLO, ADI, Arena Pharmaceuticals, CVNA, CHRS, CPRT, DICE. ETSY, FSRXW, KBR, MIST, MNST, NUVL, OPEN, PWR, RIVN, SRNE, SQ, WRBY, GRAB, TEL.
- Suvretta Capital Management was a net seller of stock by $-1.5B.
- Suvretta Capital Management has $3.3B in assets under management (AUM), dropping by -36.62%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 87 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Microsoft Corporation (MSFT) | 5.6 | $184M | -31% | 596k | 308.31 | |
| Union Pacific Corporation (UNP) | 5.1 | $168M | -24% | 614k | 273.21 | |
| Amazon (AMZN) | 4.5 | $147M | -58% | 45k | 3259.94 | |
| UnitedHealth (UNH) | 3.8 | $123M | -47% | 241k | 509.97 | |
| Lauder Estee Cos Cl A (EL) | 3.1 | $101M | -17% | 373k | 272.32 | |
| Centene Corporation (CNC) | 3.1 | $101M | NEW | 1.2M | 84.19 | |
| Otis Worldwide Corp (OTIS) | 3.0 | $100M | -47% | 1.3M | 76.95 | |
| Visa Com Cl A (V) | 3.0 | $97M | NEW | 438k | 221.77 | |
| Intra Cellular Therapies (ITCI) | 2.9 | $94M | +22% | 1.5M | 61.19 | |
| Iqvia Holdings (IQV) | 2.7 | $89M | -30% | 387k | 231.21 | |
| Las Vegas Sands (LVS) | 2.7 | $88M | NEW | 2.3M | 38.87 | |
| Tapestry (TPR) | 2.6 | $86M | -48% | 2.3M | 37.15 | |
| S&p Global (SPGI) | 2.6 | $85M | NEW | 207k | 410.18 | |
| Charles Schwab Corporation (SCHW) | 2.5 | $83M | NEW | 983k | 84.31 | |
| Humana (HUM) | 2.5 | $82M | NEW | 189k | 435.17 | |
| Royalty Pharma Shs Class A (RPRX) | 2.4 | $79M | +2% | 2.0M | 38.96 | |
| Gfl Environmental Sub Vtg Shs (GFL) | 2.3 | $74M | -50% | 2.3M | 32.54 | |
| Johnson & Johnson (JNJ) | 2.2 | $74M | NEW | 415k | 177.23 | |
| Mastercard Incorporated Cl A (MA) | 2.1 | $68M | -23% | 191k | 357.38 | |
| Danaher Corporation (DHR) | 2.1 | $68M | +5% | 233k | 293.33 | |
| Thermo Fisher Scientific (TMO) | 2.1 | $68M | -57% | 115k | 590.65 | |
| Kura Oncology (KURA) | 1.9 | $63M | +8% | 3.9M | 16.08 | |
| Fulcrum Therapeutics (FULC) | 1.9 | $62M | +10% | 2.6M | 23.65 | |
| Rh (RH) | 1.8 | $59M | -27% | 182k | 326.09 | |
| AmerisourceBergen (ABC) | 1.8 | $59M | -69% | 383k | 154.71 | |
| Hilton Worldwide Holdings (HLT) | 1.7 | $55M | -39% | 363k | 151.74 | |
| Marriott Intl Cl A (MAR) | 1.7 | $54M | -37% | 309k | 175.75 | |
| Select Sector Spdr Tr Energy (XLE) | 1.6 | $53M | NEW | 693k | 76.44 | |
| Bath & Body Works In (BBWI) | 1.5 | $50M | NEW | 1.0M | 47.80 | |
| Marqeta Class A Com (MQ) | 1.4 | $45M | +176% | 4.0M | 11.04 | |
| Mirati Therapeutics (MRTX) | 1.3 | $42M | +26% | 510k | 82.22 | |
| Deckers Outdoor Corporation (DECK) | 1.2 | $39M | -34% | 143k | 273.77 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $38M | +8% | 525k | 72.62 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.1 | $35M | +15% | 2.9M | 12.15 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $34M | 1.2M | 29.11 | ||
| Insmed Com Par $.01 (INSM) | 0.9 | $31M | +21% | 1.3M | 23.50 | |
| Sutro Biopharma (STRO) | 0.9 | $31M | +53% | 3.7M | 8.22 | |
| McKesson Corporation (MCK) | 0.9 | $30M | NEW | 98k | 306.13 | |
| Wynn Resorts (WYNN) | 0.9 | $29M | NEW | 366k | 79.74 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.8 | $26M | +4% | 2.8M | 9.35 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $26M | 1.7M | 14.74 | ||
| Point Biopharma Global (PNT) | 0.7 | $24M | +12% | 3.0M | 7.97 | |
| Natera (NTRA) | 0.7 | $24M | -8% | 585k | 40.68 | |
| Chinook Therapeutics (KDNY) | 0.7 | $24M | +14% | 1.4M | 16.36 | |
| Kezar Life Sciences (KZR) | 0.7 | $23M | 1.4M | 16.62 | ||
| Cano Health Com Cl A (CANO) | 0.7 | $23M | -62% | 3.7M | 6.35 | |
| Spdr Ser Tr S&p Oilgas Exp (XOP) | 0.7 | $22M | NEW | 165k | 134.55 | |
| Arcellx Common Stock (ACLX) | 0.7 | $22M | NEW | 1.5M | 14.02 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $21M | 692k | 30.57 | ||
| Heron Therapeutics (HRTX) | 0.5 | $16M | +15% | 2.9M | 5.72 | |
| Pharvaris N V (PHVS) | 0.5 | $15M | 828k | 18.13 | ||
| Chimerix (CMRX) | 0.4 | $13M | 2.8M | 4.58 | ||
| Mereo Biopharma Group Ads (MREO) | 0.3 | $10M | 9.1M | 1.12 | ||
| Aeglea Biotherapeutics (AGLE) | 0.3 | $9.3M | +57% | 4.1M | 2.30 | |
| Solid Biosciences (SLDB) | 0.3 | $8.7M | +14% | 7.2M | 1.20 | |
| Molecular Partners Ads (MOLN) | 0.3 | $8.2M | 400k | 20.55 | ||
| Otonomy (OTIC) | 0.2 | $7.5M | +17% | 3.1M | 2.40 | |
| Biohaven Pharmaceutical Holding (BHVN) | 0.2 | $7.3M | NEW | 62k | 118.58 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $6.8M | NEW | 406k | 16.65 | |
| Ambrx Biopharma Sponsored Ads (AMAM) | 0.2 | $6.1M | +41% | 1.5M | 4.12 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $6.1M | 2.2M | 2.74 | ||
| Inflarx Nv (IFRX) | 0.2 | $6.0M | 3.3M | 1.83 | ||
| Research Alliance Corp Ii Com Cl A (RACB) | 0.1 | $4.9M | 500k | 9.77 | ||
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $4.3M | NEW | 345k | 12.38 | |
| Inozyme Pharma (INZY) | 0.1 | $4.1M | 1.0M | 4.09 | ||
| Sio Gene Therapies Common (SIOX) | 0.1 | $4.0M | 5.9M | 0.67 | ||
| Terns Pharmaceuticals (TERN) | 0.1 | $3.7M | 1.2M | 2.97 | ||
| Roivant Sciences SHS (ROIV) | 0.1 | $3.4M | 682k | 4.94 | ||
| Gemini Therapeutics (GMTX) | 0.1 | $3.3M | 2.4M | 1.39 | ||
| Omega Alpha Spac Cl A (OMEG) | 0.1 | $2.9M | 300k | 9.82 | ||
| European Biotech Acqutn Corp Class A Ord Shs (EBAC) | 0.1 | $2.9M | 300k | 9.74 | ||
| Oric Pharmaceuticals (ORIC) | 0.1 | $2.4M | 441k | 5.34 | ||
| Opy Acquisition Corp I Unit 09/22/2026 (OHAAU) | 0.1 | $2.0M | 200k | 9.99 | ||
| Bcls Acquisition Corp Com Cl A (BLSA) | 0.1 | $2.0M | 200k | 9.87 | ||
| Turmeric Acquisition Corp Cl A (TMPM) | 0.1 | $2.0M | 200k | 9.85 | ||
| Benitec Biopharma (BNTC) | 0.1 | $1.8M | 769k | 2.34 | ||
| Immuneering Corp Class A Com (IMRX) | 0.0 | $1.3M | 200k | 6.47 | ||
| Cano Health *w Exp 06/03/202 (CANO.WS) | 0.0 | $1.1M | 674k | 1.58 | ||
| Entrada Therapeutics (TRDA) | 0.0 | $995k | 106k | 9.39 | ||
| Eucrates Biomedical Acqu Cor SHS (EUCR) | 0.0 | $984k | 100k | 9.84 | ||
| Frazier Lifesciences Acqu Cl A Shs (FLAC) | 0.0 | $860k | 88k | 9.83 | ||
| Decibel Therapeutics (DBTX) | 0.0 | $801k | 264k | 3.04 | ||
| Meiragtx Holdings (MGTX) | 0.0 | $479k | 35k | 13.84 | ||
| Turmeric Acquisition Corp *w Exp 10/08/202 (TMPMW) | 0.0 | $22k | 67k | 0.33 | ||
| European Biotech Acqutn Corp *w Exp 03/06/202 (EBACW) | 0.0 | $20k | 100k | 0.20 | ||
| Frazier Lifesciences Acqu *w Exp 11/30/202 (FLACW) | 0.0 | $7.0k | 29k | 0.24 | ||
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 (EUCRW) | 0.0 | $6.0k | 33k | 0.18 |
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2022 Q1 filed May 16, 2022
- Suvretta Capital Management 2021 Q4 filed Feb. 14, 2022
- Suvretta Capital Management 2021 Q3 restated filed Nov. 16, 2021
- Suvretta Capital Management 2021 Q3 filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q3 amended filed Nov. 15, 2021
- Suvretta Capital Management 2021 Q2 filed Aug. 16, 2021
- Suvretta Capital Management 2021 Q1 filed May 17, 2021
- Suvretta Capital Management 2020 Q4 filed Feb. 16, 2021
- Suvretta Capital Management 2020 Q3 filed Nov. 16, 2020
- Suvretta Capital Management 2020 Q2 filed Aug. 14, 2020
- Suvretta Capital Management 2020 Q1 filed May 15, 2020
- Suvretta Capital Management 2019 Q4 filed Feb. 14, 2020
- Suvretta Capital Management 2019 Q3 filed Nov. 14, 2019
- Suvretta Capital Management 2019 Q2 filed Aug. 14, 2019
- Suvretta Capital Management 2019 Q1 filed May 15, 2019
- Suvretta Capital Management 2018 Q4 filed Feb. 14, 2019